DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Ausgabe 01/02 · Volume 17 · 1967 DOI: 10.1055/s-008-39999

Originalarbeiten - Original Articles - Travaux Originaux

  • 001
    Prokopowicz, J; Worowski, K; Popławski, A; Gabryelewicz, A; Niewiarowski, S:

    Fibrinolytic System in Patients with Hypertensive Cardiovascular Disease

  • 008
    Nanninga, L. B:

    Rapid Determination of Profibrinolysin (Plasminogen) in Plasma

  • 012
    Bennett, N. B:

    A Method for the Quantitative Assay of Inhibitor of Plasminogen Activation in Human Serum

  • 023
    Rubin, H; Ritz, N. D:

    The Inhibitory Effect of Sialic Acid on Fibrinolysis

  • 031
    Egeblad, K:

    Effects on Fibrin Clot Lysis of a Trypsin Inhibitor in Peanuts (Arachis hypogaea)

  • 042
    Laursen, B; Gormsen, J:

    Spontaneous Fibrinolysis Demonstrated by Immunological Technique

  • 051
    Gormsen, J; Josephsen, P:

    The Effect of Trasylol on Blood Coagulation after Intravenous Injection

  • 058
    Hiemeyer, V; Rasche, H:

    Vergleichende Untersuchungen zur Wirkung von Urokinase und Streptokinase im Tierversuch

  • 065
    Lipinski, B; Wegezynowicz, Z; Budzynski, A. Z; Kopeć, Maria; Latallo, Z. S; Kowalski, E:

    Soluble Unclottable Complexes Formed in the Presence of Fibrinogen Degradation Products (FDP) during the Fibrinogen-Fibrin Conversion and Their Potential Significance in Pathology

  • 078
    Barnhart, M. I; Cress, D. C; Henry, R. L; Riddle, J. M:

    Influence of Fibrinogen Split Products on Platelets

  • 099
    Sinakos, Z; Caen, J. P:

    Platelet Aggregation in Mammalians (Human, Rat, Rabbit, Guinea-Pig, Horse, Dog) A Comparative Study

  • 112
    Dintenfass, L; Rozenberg, M. C:

    Effect of Temperature, Velocity Gradient and I.V. Heparin on in Vitro Blood Coagulation and Platelet Aggregation

  • 120
    Rachmilewitz, E. A; Schenker, J; Kropatkin, M. L:

    Defibrination Syndrome Followed by Hypercoagulable State

  • 129
    Huth, K; Schoenborn, W; Knorpp, KL:

    Experimentelle Verbrauchskoagulopathie nach intravenöser Zufuhr von Fett und Endotoxin

  • 144
    Graeff, H; Kuhn, W; Bleyl, U:

    Verbrauchskoagulopathie und Lysekoagulopathie bei menschlichen Äquivalenten des Sanarelli-Shwartzman-Phänomens (generalisiertes Shwartzman-Phänomen)

  • 156
    Rodríguez-Erdmann, F; Naimi, S:

    Studies on the Pathogenesis of the Generalized Shwartzman Reaction

  • 165
    Girolami, A; Cliffton, E. E:

    Hypercoagulable State Induced in Humans by the Intravenous Administration of Purified Ellagic Acid

  • 176
    Egeberg, O:

    Inherited Fibrinogen Abnormality Causing Thrombophilia

  • 188
    van Creveld, S; Mochtar, I. A; Pascha, C. N:

    Studies on the Enzymatic Activity of the Antihemophilic Factor (Factor VIII)

  • 194
    Gobbi, F; Ascari, E; Barbieri, U:

    Congenital Combined Deficiency of Factor VIII (Antihaemophilic Globulin) and Factor V (Proaccelerin) in Two Siblings

  • 205
    Baker, W. J; Seegers, W. H:

    The Conversion of Prethrombin to Thrombin

  • 214
    Shanberge, J. N; Matsuoka, T:

    The Prothrombin Time in the Newborn: Effect of Contact Activation

  • 222
    Rapaport, S. I; Hjort, P. F:

    The Blood Clotting Properties of Rabbit Peritoneal Leukocytes in Vitro

  • 237
    Regoeczi, E; Walton, P. L:

    Effects of Clotting on the Label in Iodinated Fibrinogen in Different Species

  • 247
    Kerwin, D. M; Milstone, J. H:

    Removal of Thrombokinase from Commercial Thrombin

  • 256
    Caldwell, M. J:

    The Effect of Hirudin, a Potent Antithrombin, on the Thromboplastin Generation Test

  • 264
    Allalouf, D; Ber, A; Rechnic, Jadwiga; Sharon, N:

    Anticoagulant Properties of an Acid Mucopolysaccharide Preparation Isolated from Rat Kidney

  • 273
    Kahn, M. J. P; Bourgain, R. H:

    Mechanisms of Interaction between a Phosphoinositide Anticoagulant and a Phospholipid Activator in the Stypven Type Conversion of Prothrombin to Thrombin

  • 277
    Gumińska, Maria; Eckstein, M; Stachurska, Barbara; Sulko, J:

    The Anticoagulant Activity of 3.3’-(p-Alkylthio-Benzylidene)-Bis-4-Hydroxycoumarins and Their Oxidation Products

  • 287
    Mayer, G; Mayer, S; Waitz, R; avec, la collaboration technique de Mme Bichel:

    L’Action du Facteur VIII (Globuline Antihemophilique) sur la Consommation du Facteur X pendant la Coagulation

    • Buchbesprechungen - Book Reviews - Livres Nouveaux

  • 296
    Deutsch, E:

    Clinical Haematology

  • 296
    Irsigler, K:

    Diabetes Coronary Thrombosis and the Saccharine Disease

  • 296
    Witte, S:

    Alterskrankheiten - Taschenbuch für Ärzte und Studenten

  • 297
    Beller, F. K:

    Pathogenesis and Treatment of Thromboembolic Diseases